Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125172482 | 12517248 | 2 | F | 201406 | 20160715 | 20160630 | 20160721 | EXP | JP-009507513-1606JPN012020 | MERCK | 74.00 | YR | M | Y | 78.00000 | KG | 20160721 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125172482 | 12517248 | 1 | PS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 50 MG, ONCE A DAY | U | 21995 | 50 | MG | TABLET | QD | |||||
125172482 | 12517248 | 2 | SS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | DAILY DOSAGE UNKNOWN | U | 21995 | TABLET | ||||||||
125172482 | 12517248 | 3 | SS | TENELIA | TENELIGLIPTIN | 1 | Oral | 40 MG, DIVIDED DOSE FREQUENCY UNKNOWN | 0 | 40 | MG | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125172482 | 12517248 | 1 | Type 2 diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125172482 | 12517248 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125172482 | 12517248 | Pemphigoid | |
125172482 | 12517248 | Pruritus |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125172482 | 12517248 | 1 | 201310 | 201507 | 0 | |
125172482 | 12517248 | 3 | 201507 | 20160617 | 0 |